This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Her Majesty the Queen in Right of Canada, as Represented by the Minister of National Defence. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Ashley J Meyers in Antibody Production
Introduction
Ashley J Meyers is an accomplished inventor based in Cambridge, CA. She has made significant contributions to the field of biotechnology, particularly in the production of antibodies using plant systems. Her innovative approach has the potential to enhance therapeutic applications and improve public health.
Latest Patents
Ashley J Meyers holds a patent for a method of producing ricin antibodies that bind to the ricin B chain. The patent describes a process that involves introducing nucleic acid molecules encoding the heavy and light chain variable regions of the antibody into a plant or plant cell. The plant or plant cell is then grown to produce a plant that expresses the antibody or antibody fragment. This method not only facilitates the production of anti-ricin B chain antibodies but also outlines their potential use in therapy and prophylaxis. She has 1 patent to her name.
Career Highlights
Meyers is currently employed by Her Majesty the Queen in Right of Canada, as Represented by the Minister of National Defence. Her work focuses on advancing biotechnological methods that can be applied in various fields, including medicine and environmental safety.
Collaborations
Ashley collaborates with notable colleagues such as Krishnaraj Tiwari and Jyoti Latawa, who contribute to her research and development efforts. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Ashley J Meyers exemplifies the spirit of innovation in biotechnology through her groundbreaking work on antibody production in plants. Her contributions are paving the way for new therapeutic solutions and advancing the field of biomedicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile